Consure Medical

Consure Medical focuses on developing innovative healthcare solutions aimed at enhancing patient care in incontinence management through advanced medical products. Founded in 2011 in San Francisco, US, Consure Medical specializes in healthcare products designed for stool management. The company has conducted three investment deals, with the most recent being a Series B round in April 2020, raising INR 36 million led by Accel. Founders Amit Sharma, Nish Chasmawala, and Nishith Chasmawala continue to lead the company, with Nish Chasmawala serving as CEO.

Consure Medical specializes in innovative healthcare solutions focused on improving patient care in the field of incontinence management. The company's core product offerings include the Qora SMK and Qoramatic systems, designed to automate stool management processes, reducing caregiver intervention time by up to 174 minutes daily. These products serve healthcare facilities, particularly hospitals and nursing homes, catering to critical care patients in both the United States and India. Consure Medical generates revenue through direct sales of its flagship products to healthcare institutions and facilities.

The company operates on a B2B model, supplying the Qora SMK and Qoramatic systems via direct contracts with clients such as hospitals and nursing homes. The revenue model emphasizes delivering value through enhanced patient care and operational efficiency for nursing staff, with pricing based on the needs of healthcare providers. Following the recent Series B funding of INR 36 million in April 2020 led by Accel, Consure Medical is set to leverage these resources to expand its product line and market reach. The company is currently developing new products aimed at further automating incontinence management, with plans to launch these innovations within the next year.

Moreover, Consure Medical aims to enter new markets in Europe and Southeast Asia by 2025, broadening its geographical footprint in the global healthcare sector.